Image credit- ajp.com.au
Outgoing CEO of the Generic and Biosimilar Medicines Association (GBMA), Belinda Wood has been appointed to the role of General Manager (GM), Policy and Advocacy of the Pharmaceutical Society of Australia (PSA).
Wood has over 23 years’ experience in the pharmaceutical industry, having worked constructively with policy makers and political decision-makers, and built trusted relationships with stakeholders over the past three years in her role as CEO of GBMA.
She led negotiations of the GBMA’s first ever Strategic Agreement with government in 2015, and again in 2017. Prior to holding the role of CEO, Wood was the organisation’s policy director. She has also previously worked as a policy manager for the Pharmacy Guild of Australia.
She holds a medical science degree in pharmacology from the University of Sydney, and is a graduate of the Australian Institute of Company Directors.
